SCHEMBL566949

SCHEMBL566949

COc1ccc(C=C(C)C=O)cc1OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
ALDH1A1 P00352 2/20 0.61
TSHR P16473 1/20 0.61
KDM4E B2RXH2 1/20 0.56
HPGD P15428 1/20 0.56
ALOX15 P16050 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HSD17B10 Q99714 1/20 0.56
PTGS1 P23219 2/20 0.55
PTGS2 P35354 2/20 0.55
NQO2 P16083 1/20 0.55
NFE2L2 Q16236 1/20 0.54
ABCG2 Q9UNQ0 3/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
CYP1A2 P05177 1/20 0.53
GLO1 Q04760 2/20 0.51
IKBKB O14920 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566948 1.00 GAA (0.65) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL13077183 0.86 ALDH1A1 (0.67) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL7190766 0.86 ALDH1A1 (0.67) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL6331557 0.84 ALDH1A1 (0.63) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL6331553 0.84 ALDH1A1 (0.63) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL10100314 0.83 GAA (0.47) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL4960972 0.82 APP (0.56) ALDH1A1KDM4EHPGDMAPT
SCHEMBL4960977 0.82 APP (0.56) ALDH1A1KDM4EHPGDMAPT
SCHEMBL13370881 0.81 GAA (0.68) GAATDP1ALDH1A1TSHRKDM4E
SCHEMBL19112247 0.79 TUBB4A (0.60) GAATDP1ALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018210-B2 Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing an acidic composition in the wellbore DORF KETAL CHEMICALS FZE (AE) 2024-06-25 US claimed
US-20240191128-A1 Methods for Stimulating a Hydrocarbon-bearing Formation by Perforating a Wellbore and Introducing an Acidic Composition in the Wellbore DORF KETAL CHEMICALS FZE (AE) 2024-06-13 US claimed
US-20230125900-A1 Downhole Methods HSBC BANK MIDDLE EAST LIMITED (AE) 2023-04-27 US claimed
US-20230120003-A1 Methods for Stimulating a Hydrocarbon-bearing Formation by Perforating a Wellbore and Introducing an Acidic Composition in the Wellbore HSBC BANK MIDDLE EAST LIMITED (AE) 2023-04-20 US claimed
US-11591511-B2 Methods for stimulating a hydrocarbon-bearing formation by perforating a wellbore and introducing and acidic composition in the wellbore FLUID ENERGY GROUP LTD (CA) 2023-02-28 US claimed
US-20210238469-A1 CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES CAMERON INTERNATIONAL CORPORATION 2021-08-05 US claimed
US-20210230476-A1 Novel Downhole Methods And Compositions Used in Such HSBC BANK MIDDLE EAST LIMITED (AE) 2021-07-29 US claimed
US-11066749-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2021-07-20 US claimed
US-20200173034-A1 Corrosion Inhibition of HCL Treatment Fluids with Environmentally Compatible Solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-06-04 US claimed
US-10604850-B2 Corrosion inhibition of HCL treatment fluids with environmentally compatible solvent HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-31 US claimed
US-8062586-B2 Methods and compositions for inhibiting metal corrosion HALLIBURTON ENERGY SERVICES, INC. (US) 2011-11-22 US claimed
US-7994099-B2 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALIBURTON ENERGY SERVICES, INC. (US) 2011-08-09 US claimed
WO-2010119235-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2010-10-21 WO claimed
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods HALLIBURTON ENERGY SERVICES, INC. 2010-10-14 US claimed
US-20100087340-A1 Methods and Compositions for Inhibiting Metal Corrosion HALLIBURTON ENERGY SERVICES, INC. 2010-04-08 US claimed
US-20080227668-A1 Corrosion-inhibiting additives, treatment fluids, and associated methods HALLIBURTON ENERGY SERVICES, INC. 2008-09-18 US claimed
US-20080227669-A1 Corrosion-inhibiting additives, treatment fluids, and associated methods HALLIBURTON ENERGY SERVICES, INC. 2008-09-18 US claimed
EP-1689911-A1 METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION Halliburton Energy Services, Inc. (US) 2006-08-16 EP claimed
WO-2005054544-A1 METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION HALLIBURTON ENERGY SERVICES, INC. (US) 2005-06-16 WO claimed
US-20050123437-A1 Methods and compositions for inhibiting metal corrosion HALLIBURTON ENERGY SERVICES, INC. 2005-06-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238469-A1 CORROSION INHIBITOR WITH IMPROVED PERFORMANCE AT HIGH TEMPERATURES AOC1, C5, C9 GAA 1884/4885TDP1 2101/4885ALDH1A1 457/4885
US-20100261623-A1 Corrosion inhibitor compositions comprising an aldehyde and a thiol and/or an amine functionalized ring structure and associated methods MUC1, CA1, MGMT GAA 148/4885TDP1 1722/4885ALDH1A1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.